3 Reasons Growth Investors Will Love Boston Scientific (BSX)

Boston Scientific (BSX) is identified as a compelling growth investment, supported by a favorable Zacks Growth Style Score (B) and a Zacks Rank #2 (Buy). The medical device manufacturer is projected to achieve 18.6% EPS growth this year, significantly outpacing the industry average of 10.2%, and boasts exceptional year-over-year cash flow growth of 26.5% against an industry average of 1.2%. Additionally, BSX has experienced positive current-year earnings estimate revisions, with the Zacks Consensus Estimate climbing 2.1% in the past month, positioning it as a potential outperformer for growth-oriented investors.

Analysis

Boston Scientific (BSX) is positioned as a strong growth candidate based on several key financial metrics that significantly outperform its industry peers. The medical device manufacturer is projected to achieve 18.6% EPS growth this year, substantially outpacing the industry's average forecast of 10.2%. This forward-looking momentum is supported by the company's exceptional year-over-year cash flow growth of 26.5%, which dwarfs the 1.2% industry average and indicates a strong capacity for self-funded expansion. The positive outlook is further bolstered by recent upward earnings estimate revisions, with the Zacks Consensus Estimate for the current year increasing by 2.1% over the last month, a factor often correlated with positive near-term price movement. These fundamental strengths have earned the stock a Zacks Rank #2 (Buy) and a Growth Score of B, underscoring its potential as a solid choice for growth-focused portfolios.

Key Decisions for Investors

• Given its superior growth projections in both earnings and cash flow compared to industry averages, investors with a growth mandate should consider BSX a compelling opportunity.
• The positive trend in earnings estimate revisions is a critical component of the current investment thesis, making it essential to monitor future analyst reports and consensus changes for any shifts in outlook.
• While the fundamental indicators are strong, the article notes that growth stocks carry above-average risk, so investors should manage position size to account for potential volatility.